AlexanderJamesFayMDPhD
Neurology • San Francisco, CANeuromuscular Medicine, Child Neurology
Associate Professor
Overview of Dr. Fay
Dr. Alexander Fay is a neurologist in San Francisco, CA and is affiliated with multiple hospitals in the area, including UCSF Medical Center and UCSF Benioff Children's Hospital Oakland. He received his medical degree from University of California (San Francisco) School of Medicine and has been in practice 7 years. He is one of 307 doctors at UCSF Medical Center and one of 9 doctors at UCSF Benioff Children's Hospital Oakland who specialize in Neurology. He has more than 10 publications and over 500 citings.
Office
Department if Neurology
1825 4th Street, 5th Floor, 5A
San Francisco, CA 94143Fax+1 415-353-2400
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Child Neurology, 2012 - 2015- Washington University/B-JH/SLCH ConsortiumResidency, Pediatrics, 2010 - 2012
University of California San Francisco School of MedicineClass of 2010
Certifications & Licensure
CA State Medical License 2016 - 2026
MO State Medical License 2015 - 2017- American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
- American Board of Psychiatry and Neurology Neuromuscular Medicine
Publications & Presentations
PubMed
- 347 citationsMicrotubule Plus-End-Tracking Proteins Target Gap Junctions Directly from the Cell Interior to Adherens JunctionsRobin M. Shaw, Alex J. Fay, Manojkumar A. Puthenveedu, Mark von Zastrow, Yuh Nung Jan
Cell. 2007-02-09 - 53 citationsRelapse severity and recovery in early pediatric multiple sclerosis.Alex J. Fay, Ellen M. Mowry, Jonathan B. Strober, Emmanuelle Waubant
Multiple Sclerosis. 2012-07-01 - 53 citationsGenetic, Phenotypic, and Interferon Biomarker Status in ADAR1-Related Neurological DiseaseGillian I. Rice, Naoki Kitabayashi, Magalie Barth, Tracy A Briggs, Annabel C.E. Burton
Neuropediatrics. 2017-04-10
Press Mentions
Roche’s SMA Therapy Faces Uphill Struggle Against SpinrazaAugust 6th, 2019
Muscular Dystrophy Association Celebrates FDA Approval of Argenx’s Vyvgart Hytrulo Injection for Treatment of Generalized Myasthenia GravisJune 22nd, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
